seed
Stage
About
Ophidion, Inc. is an early-stage CNS biopharmaceutical company developing a proprietary, non-invasive carrier technology to deliver gene-silencing agents and other therapeutics across the blood–brain barrier into the brain, with a pipeline focused on neurodegenerative diseases.
Explore Ophidion's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.